|New Enterprise Associates Partner Carol Gallagher|
New Enterprise Associates Partner Carol Gallagher joins FierceBiotech Radio to talk about her journey from Big Pharma to small biotech and eventually to venture capital, along the way shedding light on just what VCs do all day.
Download the episode on iTunes or listen below--and be sure to subscribe. Let us know what you think by dropping a line to firstname.lastname@example.org. And if you missed last week's interview with Michael Gilman, CEO of the Atlas Venture-seeded Padlock Therapeutics, you can find it here.